Menzel Garry E Insider Trades

Insider Trading History

Track insider trading activity for Menzel Garry E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $64.2k 30,550 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$74.2k 30,550 shares
$2.43
$2.10
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $876k 29,747 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$324k 29,747 shares
$10.90
$29.46
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Director
Holding Value $54.4k 1,121,604 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 1,121,604 shares
$1.05
$0.05
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $64.2k 30,550 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 30,550 shares
$4.65
$2.10
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $225k 7,639 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 7,639 shares
$16.41
$29.46
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Director
Holding Value $3.64k 75,056 shares
Last Trade
Jul 10, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$43.4k 47,702 shares
$0.91
$0.05
Stoke Therapeutics
Stoke Therapeutics STOK
Director
Holding Value $573k 19,441 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$242k 19,441 shares
$12.46
$29.46
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President And CEO
Holding Value $0 0 shares
Last Trade
Jun 01, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.91M 1,293,428 shares
$1.48
$1.48
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $34.7k 16,500 shares
Last Trade
May 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30k 16,500 shares
$1.82
$2.10
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President And CEO
Holding Value $352k 238,008 shares
Last Trade
Dec 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$269k 277,689 shares
$0.97
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President And CEO
Holding Value $206k 138,871 shares
Last Trade
Dec 13, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.7k 11,000 shares
$1.06
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President And CEO
Holding Value $222k 149,871 shares
Last Trade
Dec 12, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.7k 10,613 shares
$1.10
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President And CEO
Holding Value $238k 160,484 shares
Last Trade
Dec 09, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.7k 10,325 shares
$1.13
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President And CEO
Holding Value $253k 170,809 shares
Last Trade
Dec 08, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.6k 9,314 shares
$1.25
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President And CEO
Holding Value $267k 180,123 shares
Last Trade
Dec 07, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.7k 9,111 shares
$1.28
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President And CEO
Holding Value $280k 189,234 shares
Last Trade
Dec 06, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.1k 14,886 shares
$1.35
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President And CEO
Holding Value $302k 204,120 shares
Last Trade
Dec 05, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.7k 8,530 shares
$1.37
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President & CEO
Holding Value $315k 212,650 shares
Last Trade
Dec 02, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.7k 8,408 shares
$1.39
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President & CEO
Holding Value $327k 221,058 shares
Last Trade
Dec 01, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$637k 442,116 shares
$1.44
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
President And CEO
Holding Value $237k 159,956 shares
Last Trade
Nov 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$349k 262,584 shares
$1.33
$1.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up